Request Demo
Last update 08 May 2025
FindCure Biosciences (ZhongShan) Co., Ltd.
Private Company|2019|Guangdong Sheng, China
Private Company|2019|Guangdong Sheng, China
Last update 08 May 2025
Overview
Tags
Neoplasms
Digestive System Disorders
Respiratory Diseases
Small molecule drug
Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Related
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
CN115707704
Patent MiningTarget |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
CTR20243910
AXL抑制剂FC084CSA片联合替雷利珠单抗注射液治疗晚期恶性实体瘤患者的安全性、耐受性、药代动力学和有效性研究：一项单臂、开放、剂量递增、剂量扩展的Ⅰb/Ⅱa期临床研究
[Translation] Safety, tolerability, pharmacokinetics and efficacy of AXL inhibitor FC084CSA tablets combined with tislelizumab injection in the treatment of patients with advanced malignant solid tumors: a single-arm, open-label, dose-escalation, dose-expansion phase Ib/IIa clinical study
NCT06499350
A Dose-Escalation and Dose-Expansion Study of the Safety, Tolerability, Pharmacokinetics and Efficacy of AXL Inhibitor FC084CSA Tablets in Combination With Tislelizumab in the Treatment of Advanced Malignant Solid Tumors
CTR20230518
Axl抑制剂FC084CSA片在晚期恶性实体肿瘤患者中的安全性、耐受性、药代动力学特征及初步疗效的Ⅰ期临床研究
[Translation] Phase I clinical study on the safety, tolerability, pharmacokinetic characteristics and preliminary efficacy of Axl inhibitor FC084CSA tablets in patients with advanced malignant solid tumors
100 Clinical Results associated with FindCure Biosciences (ZhongShan) Co., Ltd.
Login to view more data
Login to view more data
100 Deals associated with FindCure Biosciences (ZhongShan) Co., Ltd.
Login to view more data
100 Translational Medicine associated with FindCure Biosciences (ZhongShan) Co., Ltd.
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
login
or
Pipeline
Pipeline Snapshot as of 17 Jun 2025
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Discovery
1
1
Phase 2 Clinical
Other
2
Login to view more data
Current Projects
Login to view more data
Deal
Boost your decision using our deal data.
login
or
Translational Medicine
Boost your research with our translational medicine data.
login
or
Profit
Explore the financial positions of over 360K organizations with Synapse.
login
or
Grant & Funding(NIH)
Access more than 2 million grant and funding information to elevate your research journey.
login
or
Investment
Gain insights on the latest company investments from start-ups to established corporations.
login
or
Financing
Unearth financing trends to validate and advance investment opportunities.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free